pharmaphorum

OCTOBER 20, 2020

The pandemic has triggered a change in how pharmaceutical companies are engaging with healthcare professionals. When IQVIA polled non COVID-19 treating Italian HCPs in March when the crisis was at its worst, it asked HCPs if they still welcomed pharmaceutical company engagement during the crisis. The answer was yes.

Pharmaceutical Companies 122

Pharmaceutical Companies Pharmaceutical Companies Documentation Communication 122

pharmaphorum

JUNE 8, 2021

People can opt out of the scheme by filling in a form and taking it to their GP, but campaigners have complained that this was not communicated effectively and could place an onerous workload on GPs already battling to provide care amid the pandemic.

Medical Records 98

Medical Records Pharmaceutical Companies Pharmaceutical Companies Communication 98

Pharma Marketing Network

DECEMBER 17, 2021

The wave of interest in sustainability follows the value chain from top-tier pharmaceutical companies to their suppliers of every size. About 80% of pharmaceutical companies have announced a commitment to becoming carbon-neutral or made a net-zero pledge for carbon emissions. Where do most organizations start?

Pharmaceutical Companies 103

Pharmaceutical Companies Pharmaceutical Companies Communication 103

pharmaphorum

AUGUST 17, 2020

“A lot of printed materials have been migrated to digital so that patients can opt-in to receive digital communications or HCPs can receive digital product or disease state information in the form of rep-triggered emails and microsites. Joanna Carlish. The idea is about really tapping into where the customer is in their journey.

Communication 97

Communication Insurance Packaging Pharmaceutical Companies 97

ISPE

MARCH 7, 2023

A collaborative mindset must prevail between pharmaceutical companies, suppliers, and regulators and include strategic partnerships that go beyond the pharmaceutical sector so we can move together to a more sustainable future. The risks are equally applicable to both privately owned and publicly traded companies.

Health and Personal Care Stores 52

Health and Personal Care Stores Pharmaceutical Companies Pharmaceutical Companies Communication 52

ISPE

MAY 9, 2023

In an era when the world is accelerating the development of drugs and targeted medicines using innovative technologies, pharmaceutical companies still face registration hurdles for well-characterized molecules because of redundant or additional local regulatory requirements. Published 29 February 2016. Position paper.

Documentation 52

Documentation Packaging Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

MAY 26, 2021

People can opt out of the scheme by filling in a form and taking it to their GP before 23 June, but campaigners say this has not been communicated effectively. The government’s last attempt to shake up patient data-sharing – 2013’s Care.data scheme – suffered from a number of false starts and was eventually shut down in 2016.

Communication 116

Communication Pharmaceutical Companies Pharmaceutical Companies Vaccines 116

pharmaphorum

JANUARY 18, 2023

In 2016, scientists behind a study called the Resilience Project analysed genetic data from 589,000+ people and found 13 adults who carried genetic variants that should have resulted in serious – even deadly – childhood disease, but who were apparently healthy. with their priorities.

Communication 97

Communication Medical Schools Pharmaceutical Companies Pharmaceutical Companies 97

pharmaphorum

APRIL 11, 2022

From patients, patient bodies, pharmaceutical companies, and academia, to regulatory bodies, public institutions, and small and medium-sized enterprises (SMEs), all key stakeholders must come together to help the patients who most need new medicines to access them as quickly as possible. About the author.

Pharmaceutical Companies 115

Pharmaceutical Companies Pharmaceutical Companies Vaccines Packaging 115

pharmaphorum

SEPTEMBER 21, 2020

In 2016, we began developing a potential solution, working closely with patient associations, scientific committees and advisory boards. Max Pahlow is vice president & regional commercial strategy leader (EMEA) of immunology & CVM (cardiovascular & metabolism) for the Janssen pharmaceutical companies of Johnson & Johnson.

Immunization 105

Immunization Pharmaceutical Companies Pharmaceutical Companies Communication 105

ISPE

JULY 5, 2023

For example, one pharmaceutical company that switched to CM reported a 50% reduction in operating costs, a 33% reduction in waste, an 80% reduction in manufacturing and testing cycle time, and a 66% reduction in time from testing to release. In 2016, CDER approved the first switch from batch to CM for a drug product. Jayjock, N.

FDA 52

FDA Dosage Documentation Pharmaceutical Companies 52

ISPE

SEPTEMBER 10, 2023

On this basis, country approvals covering 2016–2020 were included in the analysis. Data were collected for over 5,900 postapproval CMC changes that translated to 20,000 country submissions with approvals in 2016–2020. Global Pharmaceutical Regulation: The Challenge of Integration for Developing States.” 2 3 7 Pezzola, A.,

Documentation 98

Documentation Process Improvement Packaging Pharmaceutical Companies 98

Pharmaceutical Technology

FEBRUARY 20, 2023

About Teddy Clinical Research Laboratory : As a joint venture company established in 2016 by Dian Diagnostics (300244.SZ) SZ) and Tigermed (300347.SZ Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Research Laboratories 52

Research Laboratories Vaccines Pharmaceutical Companies Pharmaceutical Companies 52